Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
6.08
+0.19 (3.23%)
Mar 9, 2026, 3:19 PM EDT - Market open
Atea Pharmaceuticals Employees
Atea Pharmaceuticals had 55 employees as of December 31, 2025. The number of employees decreased by 1 or -1.79% compared to the previous year.
Employees
55
Change (1Y)
-1
Growth (1Y)
-1.79%
Revenue / Employee
n/a
Profits / Employee
-$2,827,661
Market Cap
484.41M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Century Therapeutics | 150 |
| Kyverna Therapeutics | 129 |
| enGene Holdings | 82 |
| Lineage Cell Therapeutics | 77 |
| Assembly Biosciences | 73 |
| CorMedix | 65 |
| Altimmune | 59 |
AVIR News
- 3 days ago - Atea Pharmaceuticals, Inc. (AVIR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 11 days ago - Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call on March 5, 2026 - GlobeNewsWire
- 13 days ago - Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026 - GlobeNewsWire
- 7 weeks ago - Atea Pharmaceuticals, Inc. (AVIR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Atea Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Atea Pharmaceuticals: Potential Best-In-Class HCV Cure With Pivotal Readouts In 2026 - Seeking Alpha